Aspartate Aminotransferase Test Kits Manufacturers

Home / Product / Liver Function / 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)
  • detail of 【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)

【AST】Aspartate Aminotransferase Assay Kit (Aspartate Substrate Method)

Usage
This kit is used to quantitatively detect the activity of aspartate aminotransferase in human serum in vitro.

 

Background of Clinical Indications

It is used for the auxiliary diagnosis of myocardial or liver injury, renal or pancreatic cell injury. Increased: AST can be increased in patients with various liver disorders. AST / ALT ratio is less than 1 in patients with early stage of liver disorder and chronic hepatitis; AST / ALT ratio is more than 1 in patients with severe liver disorder and late stage of liver disorder; AST is also increased slightly in patients with other diseases such as myocarditis, nephritis and pneumonia. AST is significantly increased in patients with toxic hepatitis, alcoholic liver disease, and biliary tract diseases.

Contact Us    PDF Download    

Packing specification

Item No. Specification (Reagent 1) Specification (Reagent 2) Packing category
A009-a 60 x 2 15 x 2 7170
A009-a12 60 x 4 60 x 1 7170 Big package
A009-b 80 x 2 20 x 2 7060
A009-b12 80 x 4 80 x 1 7060 Big package
A009-c 80 x 2 20 x 2 Beckman CX series/LX20 series/DXC600/800 series、AU series etc.
A009-d 40 x 2 10 x 2 TBA 120FR/TBA 2000FR/TBA40FR

Feedback